Clinical-Grade Stem Cells Fail to Replicate Benefit of Research Lines – Alzforum
Alzforum |
Clinical-Grade Stem Cells Fail to Replicate Benefit of Research Lines
Alzforum In May 2016, researchers at the now-defunct StemCells Inc., Newark, California, terminated a Phase 2 trial of neural stem cells for spinal cord injury due to lack of efficacy. Now, two papers in the February 14 Stem Cell Reports argue that this outcome … |
